» Articles » PMID: 39334964

Synthesis and Biological Evaluation of Novel Imidazole Derivatives As Antimicrobial Agents

Overview
Journal Biomolecules
Publisher MDPI
Date 2024 Sep 28
PMID 39334964
Authors
Affiliations
Soon will be listed here.
Abstract

Imidazole derivatives are considered potential chemical compounds that could be therapeutically effective against several harmful pathogenic microbes. The chemical structure of imidazole, with a five-membered heterocycle, three carbon atoms, and two double bonds, tends to show antibacterial activities. In the present study, novel imidazole derivatives were designed and synthesized to be evaluated as antimicrobial agents owing to the low number of attempts to discover new antimicrobial agents and the emerging cases of antimicrobial resistance. Two imidazole compounds were prepared and evaluated as promising candidates regarding in vitro cytotoxicity against human skin fibroblast cells and antimicrobial activity against several bacterial strains. The synthesized imidazole derivatives were chemically identified using nuclear magnetic resonance (NMR) and Fourier-transform infrared spectroscopy (FTIR). The results demonstrated a relatively high cell viability of one of the imidazole derivatives, i.e., HL2, upon 24 and 48 h cell exposure. Both derivatives were able to inhibit the growth of the tested bacterial strains. This study provides valuable insight into the potential application of imidazole derivatives for treating microbial infections; however, further in vitro and in vivo studies are required to confirm their safety and effectiveness.

References
1.
Raghu M, Pradeep Kumar C, Yogesh Kumar K, Prashanth M, Alshahrani M, Ahmad I . Design, synthesis and molecular docking studies of imidazole and benzimidazole linked ethionamide derivatives as inhibitors of InhA and antituberculosis agents. Bioorg Med Chem Lett. 2022; 60:128604. DOI: 10.1016/j.bmcl.2022.128604. View

2.
Wang Z, Zhang Y, Pinkas D, Fox A, Luo J, Huang H . Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2- a]pyrazin-3-ylethynyl)-4-isopropyl- N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2. J Med Chem. 2018; 61(17):7977-7990. PMC: 6287892. DOI: 10.1021/acs.jmedchem.8b01045. View

3.
Ghannoum M, Rice L . Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev. 1999; 12(4):501-17. PMC: 88922. DOI: 10.1128/CMR.12.4.501. View

4.
Yang X, Song X, Banerjee S, Li Y, Byun Y, Liu G . Developing imidazoles as CEST MRI pH sensors. Contrast Media Mol Imaging. 2016; 11(4):304-12. PMC: 5201433. DOI: 10.1002/cmmi.1693. View

5.
Gratal P, Arias-Perez M, Gude L . 1H-imidazo[4,5-f][1,10]phenanthroline carbohydrate conjugates: Synthesis, DNA interactions and cytotoxic activity. Bioorg Chem. 2022; 125:105851. DOI: 10.1016/j.bioorg.2022.105851. View